✦ LIBER ✦

Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension

✍ Scribed by David Montani; Marie-Camille Chaumais; Laurent Savale; Delphine Natali; Laura C. Price; Xavier Jaïs; Marc Humbert; Gérald Simonneau; Olivier Sitbon

Publisher: Springer Healthcare Communications
Year: 2009
Tongue: English
Weight: 216 KB
Volume: 26
Category: Article
ISSN: 0741-238X
DOI: 10.1007/s12325-009-0064-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Type 5 phosphodiesterase inhibition in h

Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension

✍ Gregory D. Lewis; Marc J. Semigran 📂 Article 📅 2004 🏛 Current Science Inc. 🌐 English ⚖ 332 KB

Nonurologic applications of phosphodiest

Nonurologic applications of phosphodiesterase type 5 inhibitors

✍ Rakesh C. Kukreja; Fadi N. Salloum; Lei Xi 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 274 KB

Phosphodiesterase type 5 inhibitors and

Phosphodiesterase type 5 inhibitors and endothelial function

✍ Antonio Aversa; Roberto Bruzziches 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 146 KB

Chronic dosing of phosphodiesterase type

Chronic dosing of phosphodiesterase type 5 inhibitors

✍ Craig F. Donatucci 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 218 KB

Severe pulmonary arterial hypertension i

Severe pulmonary arterial hypertension in type 1 glycogen storage disease

✍ Marc Humbert; Philippe Labrune; Gérald Simonneau 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 70 KB

Arterial methemoglobin level predicts th

Arterial methemoglobin level predicts therapeutic effectiveness of the PDE5 inhibitors in patients with in idiopathic pulmonary arterial hypertension

✍ Yuichi Tamura; Tomohiko Ono; Takashi Kawakami; Masaharu Kataoka; Motoaki Sano; T 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 95 KB